Solventum forecasts annual profit above estimates on strong surgical product sales
M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.
Solventum price target raised to $75 from $73 at Wells Fargo
Wells Fargo raised the firm’s price target on Solventum (SOLV) to $75 from $73 and keeps an Equal Weight rating on the shares. The Q4 beat was ...
Solventum price target raised to $84 from $75 at Piper Sandler
Piper Sandler raised the firm’s price target on Solventum (SOLV) to $84 from $75 and keeps a Neutral rating on the shares. The firm notes ...
First to the Finish--a New Docuseries Focused on the Relentless Pursuit of the MX-5 Cup Championship-- Will Premiere March 25 on Prime Video
Prime Video announced a March 25 premiere date and revealed the debut trailer for First to the Finish, made in-partnership ...
Surprising news slams IonQ stock price
The ability to solve seemingly previously unsolvable problems with quantum computing unleashed a torrent of speculation over ...